Cholicamidebeta (compound 6), a self-assembling small molecule cancer vaccine adjuvant, forms low cytotoxicity virus-like particles and upon binding to peptide antigens, enhances dendritic cell-mediated antigen presentation and induces antigen-specific T-cell responses, with the ability to induce apoptosis and necrosis [1].
Molecular Weight:
879.34
Formula:
C55H94N2O6
Target:
Necroptosis|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
